Joseph Q Ta
Otolaryngology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Joseph Q Ta’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94818 · Current
Licensed to practise in California · since 2006 · expires 2028-04-30 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$111,104
Medicare paid this office $111,104 for 359 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 202 | $37,170 | $110 |
| Diagnostic exam of nasal passages using an endoscope | 41 | $13,540 | $196 |
| New patient visit (45+ min) | 87 | $12,252 | $141 |
| Removal of impacted ear wax | 145 | $9,288 | $41 |
| Short return visit (20+ min) | 77 | $6,959 | $72 |
See all 8 services
| Return visit (30+ min) | 202 | $37,170 | $110 |
| Diagnostic exam of nasal passages using an endoscope | 41 | $13,540 | $196 |
| New patient visit (45+ min) | 87 | $12,252 | $141 |
| Removal of impacted ear wax | 145 | $9,288 | $41 |
| Short return visit (20+ min) | 77 | $6,959 | $72 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | $6,087 | $130 |
| New patient visit (30+ min) | 32 | $2,739 | $86 |
| Long return visit (40+ min) | 16 | $2,459 | $154 |
Who their Medicare patients are
359 Original Medicare patients in 2024. Average age 77 · Women 54% · Also on Medicaid 6% · Health risk score 0.94. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 59% · Coronary heart disease 24% · Chronic kidney disease 20% · Diabetes 19% · Atrial fibrillation 15% · Cancer 14% · Depression 14% · Heart failure 10% · COPD 8% · Stroke 4% · Dementia 3%.
The office billed $462,552, Medicare allowed $151,218 and paid $111,104; for 1,010 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 359 | 1,010 | 77 | 0.94 | $462,552 | $111,104 |
| 2023 | 393 | 1,046 | 77 | 1.02 | $488,420 | $125,460 |
| 2022 | 376 | 929 | 77 | 0.85 | $413,490 | $104,324 |
| 2021 | 406 | 917 | 77 | 0.93 | $382,796 | $103,339 |
| 2020 | 287 | 609 | 76 | 1.05 | $249,229 | $62,633 |
| 2019 | 348 | 766 | 75 | 0.90 | $322,241 | $81,961 |
| 2018 | 361 | 778 | 76 | 0.94 | $299,578 | $76,745 |
| 2017 | 357 | 741 | 77 | 1.06 | $272,068 | $72,104 |
| 2016 | 315 | 630 | 76 | 0.96 | $235,314 | $62,307 |
| 2015 | 328 | 799 | 75 | 0.99 | $297,516 | $89,696 |
| 2014 | 223 | 552 | 73 | 1.10 | $252,973 | $74,844 |
| 2013 | 129 | 371 | 71 | 1.62 | $178,064 | $53,589 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 187 | $34,113 | $117 |
| New patient visit (45+ min) | 106 | $14,994 | $141 |
| Diagnostic exam of nasal passages using an endoscope | 39 | $10,735 | $199 |
| Removal of impacted ear wax | 150 | $9,520 | $44 |
| Short return visit (20+ min) | 100 | $9,244 | $71 |
| Diagnostic exam of voice box using a flexible endoscope | 45 | $6,218 | $132 |
| New patient visit (30+ min) | 36 | $3,321 | $92 |
| Long return visit (40+ min) | 19 | $3,290 | $157 |
| New patient visit (60+ min) | 13 | $2,728 | $210 |
2022: 9 services
| Return visit (30+ min) | 130 | $19,565 | $110 |
| Short return visit (20+ min) | 135 | $14,063 | $78 |
| New patient visit (45+ min) | 86 | $12,980 | $151 |
| Diagnostic exam of nasal passages using an endoscope | 33 | $7,999 | $200 |
| Removal of impacted ear wax | 135 | $7,748 | $40 |
| Diagnostic exam of voice box using a flexible endoscope | 35 | $4,744 | $128 |
| New patient visit (30+ min) | 55 | $4,743 | $86 |
| New patient visit (60+ min) | 11 | $2,255 | $205 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $265 | $24 |
2021: 9 services
| Return visit (30+ min) | 137 | $18,846 | $112 |
| New patient visit (45+ min) | 97 | $13,678 | $141 |
| Short return visit (20+ min) | 111 | $12,083 | $81 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $9,026 | $205 |
| Removal of impacted ear wax | 136 | $7,627 | $40 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $7,542 | $135 |
| New patient visit (30+ min) | 64 | $6,178 | $97 |
| Long return visit (40+ min) | 11 | $1,654 | $150 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 12 | $577 | $48 |
2020: 8 services
| Return visit (30+ min) | 81 | $10,399 | $96 |
| Short return visit (20+ min) | 90 | $7,965 | $65 |
| New patient visit (45+ min) | 51 | $6,642 | $130 |
| New patient visit (30+ min) | 53 | $5,210 | $98 |
| Removal of impacted ear wax | 96 | $4,949 | $40 |
| Diagnostic exam of nasal passages using an endoscope | 18 | $4,301 | $205 |
| Diagnostic exam of voice box using a flexible endoscope | 25 | $3,773 | $118 |
| Control of bleeding of nose using an endoscope | 13 | $3,299 | $254 |
2019: 9 services
| Short return visit (20+ min) | 107 | $10,477 | $63 |
| Return visit (30+ min) | 82 | $9,621 | $101 |
| New patient visit (45+ min) | 67 | $9,314 | $139 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $7,934 | $203 |
| New patient visit (30+ min) | 69 | $6,529 | $95 |
| Diagnostic exam of voice box using a flexible endoscope | 50 | $6,209 | $113 |
| Removal of impacted ear wax | 104 | $4,968 | $37 |
| Control of bleeding of nose using an endoscope | 12 | $3,124 | $240 |
| New patient visit (15+ min) | 11 | $736 | $67 |
2018: 7 services
| Short return visit (20+ min) | 127 | $11,764 | $62 |
| New patient visit (30+ min) | 100 | $9,109 | $91 |
| Return visit (30+ min) | 68 | $6,944 | $95 |
| New patient visit (45+ min) | 49 | $6,803 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $6,626 | $109 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $5,817 | $208 |
| Removal of impacted ear wax | 109 | $5,721 | $40 |
2017: 11 services
| New patient visit (30+ min) | 143 | $12,879 | $90 |
| Short return visit (20+ min) | 123 | $12,181 | $65 |
| Return visit (30+ min) | 58 | $5,648 | $96 |
| Removal of impacted ear wax | 93 | $4,839 | $42 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $4,393 | $209 |
| Diagnostic exam of voice box using a flexible endoscope | 36 | $4,261 | $109 |
| New patient visit (45+ min) | 30 | $4,113 | $137 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $3,778 | $222 |
| Control of bleeding of nose using an endoscope | 11 | $2,765 | $251 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 | $676 | $38 |
| Short return visit | 13 | $505 | $39 |
2016: 8 services
| New patient visit (30+ min) | 124 | $11,190 | $90 |
| Short return visit (20+ min) | 98 | $8,363 | $62 |
| Diagnostic exam of nasal passages using an endoscope | 33 | $7,889 | $213 |
| Return visit (30+ min) | 53 | $4,857 | $90 |
| Removal of impacted ear wax | 91 | $4,442 | $42 |
| Diagnostic exam of voice box using a flexible endoscope | 34 | $4,147 | $109 |
| New patient visit (45+ min) | 14 | $1,746 | $125 |
| Short return visit | 18 | $999 | $40 |
2015: 11 services
| New patient visit (30+ min) | 114 | $11,467 | $101 |
| Short return visit (20+ min) | 96 | $11,057 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 40 | $10,815 | $200 |
| Return visit (30+ min) | 72 | $7,701 | $97 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 15 | $6,872 | $255 |
| New patient visit (45+ min) | 44 | $6,837 | $155 |
| Diagnostic exam of voice box using a flexible endoscope | 48 | $5,915 | $114 |
| Removal of impacted ear wax | 98 | $4,989 | $43 |
| Control of bleeding of nose using an endoscope | 11 | $3,044 | $254 |
| New patient visit (15+ min) | 11 | $780 | $71 |
| Short return visit | 12 | $568 | $44 |
2014: 9 services
| New patient visit (30+ min) | 84 | $7,510 | $89 |
| Diagnostic exam of nasal passages using an endoscope | 29 | $7,212 | $195 |
| Short return visit (20+ min) | 84 | $6,685 | $62 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $4,978 | $226 |
| Diagnostic exam of voice box using a flexible endoscope | 29 | $3,302 | $107 |
| Return visit (30+ min) | 27 | $2,676 | $96 |
| Removal of impacted ear wax | 54 | $2,112 | $39 |
| New patient visit (45+ min) | 13 | $1,787 | $137 |
| Short return visit | 22 | $1,142 | $36 |
2013: 7 services
| Diagnostic exam of nasal passages using an endoscope | 26 | $5,055 | $158 |
| New patient visit (30+ min) | 55 | $4,621 | $84 |
| Short return visit (20+ min) | 49 | $3,878 | $55 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $1,458 | $97 |
| New patient visit (45+ min) | 12 | $1,404 | $117 |
| Removal of impacted ear wax | 21 | $855 | $37 |
| Short return visit | 16 | $792 | $36 |
Drugs they prescribed that Part D paid
$6,303
Pharmacies billed $6,303 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
215 generic and fewer than 11 brand-name prescriptions · $6,303 in drug cost · 56 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 30 | $1,394 | $46 |
| Ciprofloxacin-Dexamethasone | 11 | $1,383 | $126 |
| Fluticasone Propionate | 20 | $419 | $21 |
| Gabapentin | 13 | $300 | $23 |
| Amoxicillin-Clavulanate Potass | 23 | $227 | $10 |
Year by year
| 2024 | 225 | 101 | None | None | $6,303 |
| 2023 | 273 | 110 | None | None | $9,920 |
| 2022 | 207 | 110 | None | None | $7,270 |
| 2021 | 192 | 103 | None | None | $6,218 |
| 2020 | 110 | 58 | None | None | $6,005 |
| 2019 | 115 | 71 | None | None | $4,591 |
| 2018 | 141 | 74 | None | None | $5,367 |
| 2017 | 183 | 94 | None | 7% | $6,424 |
| 2016 | 158 | 70 | None | 17% | $8,556 |
| 2015 | 216 | 85 | None | 21% | $9,214 |
| 2014 | 157 | 64 | 8% (13) | 10% | $4,075 |
| 2013 | 149 | 41 | 13% (20) | 8% | $2,908 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ciprofloxacin-Dexamethasone | 12 | $1,974 | $164 |
| Ipratropium | 31 | $1,741 | $56 |
| Azelastine | 22 | $727 | $33 |
| Fluticasone Propionate | 21 | $470 | $22 |
| Gabapentin | 23 | $429 | $19 |
| Triamcinolone Acetonide | 11 | $400 | $36 |
| Amoxicillin-Clavulanate Potass | 26 | $311 | $12 |
2022: 5 drugs
| Ipratropium | 39 | $2,017 | $52 |
| Triamcinolone Acetonide | 16 | $685 | $43 |
| Fluticasone Propionate | 25 | $498 | $20 |
| Amoxicillin-Clavulanate Potass | 17 | $231 | $14 |
| Prednisone | 14 | $78 | $6 |
2021: 7 drugs
| Ipratropium | 21 | $1,235 | $59 |
| Neomycin-Polymyxin-Hydrocort | 12 | $734 | $61 |
| Triamcinolone Acetonide | 13 | $662 | $51 |
| Fluticasone Propionate | 14 | $541 | $39 |
| Amoxicillin-Clavulanate Potass | 23 | $343 | $15 |
| Prednisone | 19 | $111 | $6 |
| Methylprednisolone | 12 | $82 | $7 |
2020: 1 drug
| Ipratropium | 22 | $1,834 | $83 |
2019: 2 drugs
| Ipratropium | 19 | $1,114 | $59 |
| Neomycin-Polymyxin-Hydrocort | 11 | $742 | $67 |
2018: 5 drugs
| Ipratropium | 21 | $1,017 | $48 |
| Neomycin-Polymyxin-Hydrocort | 16 | $816 | $51 |
| Methylprednisolone | 17 | $186 | $11 |
| Amoxicillin-Clavulanate Potass | 16 | $179 | $11 |
| Prednisone | 11 | $39 | $4 |
2017: 6 drugs
| Ipratropium | 34 | $1,272 | $37 |
| Neomycin-Polymyxin-Hydrocort | 14 | $532 | $38 |
| Omeprazole | 23 | $306 | $13 |
| Methylprednisolone | 17 | $218 | $13 |
| Amoxicillin-Clavulanate Potass | 14 | $208 | $15 |
| Prednisone | 14 | $76 | $5 |
2016: 5 drugs
| Dexilant | 11 | $3,071 | $279 |
| Ipratropium | 24 | $389 | $16 |
| Omeprazole | 21 | $182 | $9 |
| Fluticasone Propionate | 17 | $160 | $9 |
| Prednisone | 12 | $68 | $6 |
2015: 8 drugs
| Dexilant | 11 | $2,565 | $233 |
| Ciprodex | 11 | $1,913 | $174 |
| Fluticasone Propionate | 43 | $516 | $12 |
| Sucralfate | 11 | $505 | $46 |
| Ipratropium | 18 | $415 | $23 |
| Methylprednisolone | 14 | $249 | $18 |
| Omeprazole | 21 | $208 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $176 | $16 |
2014: 4 drugs
| Fluticasone Propionate | 35 | $578 | $17 |
| Omeprazole | 25 | $369 | $15 |
| Pantoprazole | 11 | $151 | $14 |
| Hydrocodone-Acetaminophen | 13 | $92 | $7 |
2013: 3 drugs
| Azithromycin | 14 | $359 | $26 |
| Omeprazole | 22 | $298 | $14 |
| Hydrocodone-Acetaminophen | 11 | $99 | $9 |
Money from drug and device companies
$151 in 2025
| 2025 | 2 | 7 | None | $151 |
| 2024 | 1 | 1 | None | $19 |
| 2023 | 1 | 3 | None | $46 |
| 2020 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Halo | $105 | 6 payments
|
| Inspire Medical Systems | Inspire | $46 | 1 payment
|
See all 7 published payments
| Smith+Nephew | Meals · 2025-12-14 | Halo | $14 |
| Smith+Nephew | Meals · 2025-12-05 | Halo | $23 |
| Smith+Nephew | Meals · 2025-12-01 | Halo | $17 |
| Smith+Nephew | Meals · 2025-11-24 | Halo | $16 |
| Smith+Nephew | Meals · 2025-11-21 | Halo | $15 |
| Smith+Nephew | Meals · 2025-11-10 | Halo | $19 |
| Inspire Medical Systems | Meals · 2025-02-20 | Inspire | $46 |
See earlier years (2024, 2023, 2020)
2024: $19
| Smith+Nephew | Halo | $19 | 1 payment
|
2023: $46
| Smith+Nephew | Halo | $46 | 3 payments
|
2020: $22
| Daiichi Sankyo | Injectafer | $22 | 1 payment
|
Professional record
- NPI
- 1669650925
- Licence
- CA A94818, MI 4301097726, NV 14448California A94818: Current · expires 2028-04-30
- Trained
- Georgetown University School of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-02-08
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.